Efficacy of panthenol‐ and bisabolol‐containing lip care as monotherapy for mild‐to‐moderate cheilitis

Abstract

AbstractBackgroundCheilitis is a chronic inflammatory condition of the lips, and frequent or prolonged use of topical corticosteroids may lead to various adverse events. Therefore, alternative therapies with fewer side effects are beneficial for the treatment of this condition.AimTo evaluate the efficacy of a lip care formulation containing both panthenol and bisabolol as a monotherapy for mild‐to‐moderate cheilitis.MethodsThis single‐centre prospective pilot open‐label study included 20 patients with mild‐to‐moderate cheilitis who were treated with the tested lip care for 8 weeks and evaluated by physician and patient assessments before the final efficacy was determined using the Visioscan score.ResultsOf the 20 patients, 13 (65.0%) presented with moderate cheilitis with dry and chapped lips. All parameters, including physician and patient clinical scores and bioengineering measurements, showed significant improvements as early as week 2 and sustained until week 8 following the application of the tested lip care. The frequency of cheilitis flareups also decreased significantly. The tested product was well tolerated without any adverse effects.ConclusionsLip care with panthenol and bisabolol was safe and effective. It can be used as monotherapy for the treatment of mild‐to‐moderate cheilitis.